{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:25:35Z","timestamp":1725063935725},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,30]]},"DOI":"10.7759\/cureus.68246","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T22:44:31Z","timestamp":1725057871000},"source":"Crossref","is-referenced-by-count":0,"title":["Octreotide Causing Hyperkalemia: A Case Report and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Sandeep","family":"Sasidharan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabu","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isha","family":"Puri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Mallappallil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02850209","article-title":"The effectiveness of various doses of octreotide for sulfonylurea-induced hypoglycemia after overdose","volume":"23","author":"Gul M","year":"2006","unstructured":"Gul M, Cander B, Girisgin S, Ayan M, Kocak S, Unlu A. The effectiveness of various doses of octreotide for sulfonylurea-induced hypoglycemia after overdose. Adv Ther. 2006, 23:878-84. 10.1007\/BF02850209","journal-title":"Adv Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-1059","article-title":"Management of endocrine disease: acromegaly and pregnancy: a contemporary review","volume":"177","author":"Abucham J","year":"2017","unstructured":"Abucham J, Bronstein MD, Dias ML. Management of endocrine disease: acromegaly and pregnancy: a contemporary review. Eur J Endocrinol. 2017, 177:10.1530\/EJE-16-1059","journal-title":"Eur J Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.22451","article-title":"Octreotide for acute esophageal variceal bleeding: a meta-analysis","volume":"120","author":"Corley DA","year":"2001","unstructured":"Corley DA, Cello JP, Adkisson W, Ko WF, Kerlikowske K. Octreotide for acute esophageal variceal bleeding: a meta-analysis. Gastroenterology. 2001, 120:946-54. 10.1053\/gast.2001.22451","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli P","year":"1999","unstructured":"Angeli P, Volpin R, Gerunda G, et al.. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology. 1999, 29:1690-7. 10.1002\/hep.510290629","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1016\/S0889-8529(18)30391-8","article-title":"Hypoglycemia associated with renal failure","volume":"18","author":"Arem R","year":"1989","unstructured":"Arem R. Hypoglycemia associated with renal failure. Endocrinol Metab Clin North Am. 1989, 18:103-21.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.76.3.8445035","article-title":"Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses","volume":"76","author":"Boyle PJ","year":"1993","unstructured":"Boyle PJ, Justice K, Krentz AJ, Nagy RJ, Schade DS. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. J Clin Endocrinol Metab. 1993, 76:752-6. 10.1210\/jcem.76.3.8445035","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12822","article-title":"Treatment of sulfonylurea and insulin overdose","volume":"81","author":"Klein-Schwartz W","year":"2016","unstructured":"Klein-Schwartz W, Stassinos GL, Isbister GK. Treatment of sulfonylurea and insulin overdose. Br J Clin Pharmacol. 2016, 81:496-504. 10.1111\/bcp.12822","journal-title":"Br J Clin Pharmacol"},{"key":"ref8","article-title":"Rapid reversal of life-threatening hypoglycaemia with a somatostatin analogue (octreotide). A case report","volume":"74","author":"Alberts AS","year":"1988","unstructured":"Alberts AS, Falkson G. Rapid reversal of life-threatening hypoglycaemia with a somatostatin analogue (octreotide). A case report. S Afr Med J. 1988, 74:75-6.","journal-title":"S Afr Med J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1996.tb03729.x","article-title":"Individual sulfonylureas and serious hypoglycemia in older people","volume":"44","author":"Shorr RI","year":"1996","unstructured":"Shorr RI, Ray WA, Daugherty JR, Griffin MR. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc. 1996, 44:751-5. 10.1111\/j.1532-5415.1996.tb03729.x","journal-title":"J Am Geriatr Soc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq381","article-title":"Severe hyperkalaemia resulting from octreotide use in a haemodialysis patient","volume":"25","author":"Adabala M","year":"2010","unstructured":"Adabala M, Jhaveri KD, Gitman M. Severe hyperkalaemia resulting from octreotide use in a haemodialysis patient. Nephrol Dial Transplant. 2010, 25:3439-42. 10.1093\/ndt\/gfq381","journal-title":"Nephrol Dial Transplant"},{"key":"ref11","article-title":"","author":"Goldfrank LR","year":"2006","unstructured":"Goldfrank LR, Hoffman RS. Goldfrank\u2019s Toxicologic Emergencies. McGraw-Hill, 2006."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051682","article-title":"Somatostatin analogs in clinical practice: a review","volume":"21","author":"Gomes-Porras M","year":"2020","unstructured":"Gomes-Porras M, C\u00e1rdenas-Salas J, \u00c1lvarez-Escol\u00e1 C. Somatostatin analogs in clinical practice: a review. Int J Mol Sci. 2020, 21:10.3390\/ijms21051682","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(18)88958-X","article-title":"The mechanism of insulin stimulation of (Na+,K+)-ATPase transport activity in muscle","volume":"260","author":"Rosi\u0107 NK","year":"1985","unstructured":"Rosi\u0107 NK, Standaert ML, Pollet RJ. The mechanism of insulin stimulation of (Na+,K+)-ATPase transport activity in muscle. J Biol Chem. 1985, 260:6206-12.","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/106002809703100217","article-title":"Octreotide in hyperinsulinism","volume":"31","author":"Barrons RW","year":"1997","unstructured":"Barrons RW. Octreotide in hyperinsulinism. Ann Pharmacother. 1997, 31:239-41. 10.1177\/106002809703100217","journal-title":"Ann Pharmacother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.1998.11.s1.143","article-title":"Preoperative use of octreotide in a newborn with persistent hyperinsulinemic hypoglycemia of infancy","volume":"11","author":"Apak RA","year":"1998","unstructured":"Apak RA, Yurdak\u00f6k M, Oran O, Senocak ME, Ca\u011flar M. Preoperative use of octreotide in a newborn with persistent hyperinsulinemic hypoglycemia of infancy. J Pediatr Endocrinol Metab. 1998, 11:143-5. 10.1515\/jpem.1998.11.s1.143","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.anclin.2017.01.021","article-title":"Pharmacology of octreotide: clinical implications for anesthesiologists and associated risks","volume":"35","author":"Borna RM","year":"2017","unstructured":"Borna RM, Jahr JS, Kmiecik S, Mancuso KF, Kaye AD. Pharmacology of octreotide: clinical implications for anesthesiologists and associated risks. Anesthesiol Clin. 2017, 35:327-39. 10.1016\/j.anclin.2017.01.021","journal-title":"Anesthesiol Clin"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-014-0074-y","article-title":"Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy","volume":"4","author":"Lapa C","year":"2014","unstructured":"Lapa C, Werner RA, Bluemel C, et al.. Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy. EJNMMI Res. 2014, 4:74. 10.1186\/s13550-014-0074-y","journal-title":"EJNMMI Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.07.618","article-title":"Do not be brash: octreotide-induced syndrome of bradycardia, renal failure, atrioventricular nodal blockade, shock, and hyperkalemia","volume":"160","author":"Patel H","year":"2021","unstructured":"Patel H. Do not be brash: octreotide-induced syndrome of bradycardia, renal failure, atrioventricular nodal blockade, shock, and hyperkalemia. Chest. 2021, 160:10.1016\/j.chest.2021.07.618","journal-title":"Chest"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1159\/000186606","article-title":"Somatostatin-induced hyperkalemia in a patient on maintenance hemodialysis","volume":"59","author":"Sharma AM","year":"1991","unstructured":"Sharma AM, Thiede HM, Keller F. Somatostatin-induced hyperkalemia in a patient on maintenance hemodialysis. Nephron. 1991, 59:445-8. 10.1159\/000186606","journal-title":"Nephron"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1002\/j.1875-9114.1994.tb02843.x","article-title":"Octreotide-induced hyperkalemia","volume":"14","author":"Sargent AI","year":"1994","unstructured":"Sargent AI, Overton CC, Kuwik RJ, Varcelotti JR, Deppe SA. Octreotide-induced hyperkalemia. Pharmacotherapy. 1994, 14:497-501.","journal-title":"Pharmacotherapy"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/0148607196020006429","article-title":"Hyperkalemia secondary to concurrent pharmacotherapy in a patient receiving home parenteral nutrition","volume":"20","author":"Brown RO","year":"1996","unstructured":"Brown RO, Hamrick KD, Dickerson RN, Lee N, Parnell DH Jr, Kudsk KA. Hyperkalemia secondary to concurrent pharmacotherapy in a patient receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr. 1996, 20:429-32. 10.1177\/0148607196020006429","journal-title":"JPEN J Parenter Enteral Nutr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/267525-octreotide-causing-hyperkalemia-a-case-report-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T22:44:37Z","timestamp":1725057877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/267525-octreotide-causing-hyperkalemia-a-case-report-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.68246","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,30]]}}}